Companion Diagnostic Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Companion Diagnostic Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxxxxxxxxxx13.6%
North Americaxxxxxxxxxxxxxxxx
United Statesxxxxxxxxxxxxxxxx
Canadaxxxxxxxxxxxxxxxx
Mexicoxxxxxxxxxxxxxxxx
Europexxxxxxxxxxxxxxxx
United Kingdomxxxxxxxxxxxxxxxx
Francexxxxxxxxxxxxxxxx
Germanyxxxxxxxxxxxxxxxx
Italyxxxxxxxxxxxxxxxx
Russiaxxxxxxxxxxxxxxxx
Spainxxxxxxxxxxxxxxxx
Swedenxxxxxxxxxxxxxxxx
Denmarkxxxxxxxxxxxxxxxx
Switzerlandxxxxxxxxxxxxxxxx
Luxembourgxxxxxxxxxxxxxxxx
Rest of Europexxxxxxxxxxxxxxxx
Asia Pacificxxxxxxxxxxxxxxxx
Chinaxxxxxxxxxxxxxxxx
Japanxxxxxxxxxxxxxxxx
South Koreaxxxxxxxxxxxxxxxx
Indiaxxxxxxxxxxxxxxxx
Australiaxxxxxxxxxxxxxxxx
Singaporexxxxxxxxxxxxxxxx
Taiwanxxxxxxxxxxxxxxxx
South East Asiaxxxxxxxxxxxxxxxx
Rest of APACxxxxxxxxxxxxxxxx
South Americaxxxxxxxxxxxxxxxx
Brazilxxxxxxxxxxxxxxxx
Argentinaxxxxxxxxxxxxxxxx
Colombiaxxxxxxxxxxxxxxxx
Peruxxxxxxxxxxxxxxxx
Chilexxxxxxxxxxxxxxxx
Rest of South Americaxxxxxxxxxxxxxxxx
Middle Eastxxxxxxxxxxxxxxxx
Saudi Arabiaxxxxxxxxxxxxxxxx
Turkeyxxxxxxxxxxxxxxxx
UAExxxxxxxxxxxxxxxx
Egyptxxxxxxxxxxxxxxxx
Qatarxxxxxxxxxxxxxxxx
Rest of Middle Eastxxxxxxxxxxxxxxxx
Africaxxxxxxxxxxxxxxxx
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africaxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis


Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

Companion Diagnostic Market News

  • Labcorp and OmniSeq have launched a next-generation sequencing platform to advance precision oncology

In June 2021, Labcorp and OmniSeq, has launched of OmniSeq INSIGHTsm, a comprehensive genomic and immune profiling, tissue-based test that integrates next-generation sequencing (NGS) technology. This is designed to advance precision oncology and improve patient outcomes.

Click any bar or cell to request the full company profile
Company2022 (A)2023 (A)2024 (A)2025 (A)
Abbott Laboratories Molecular Inc••• ••• ••• •••
Agilent••• ••• ••• •••
ARUP Laboratories Inc••• ••• ••• •••
BioMerieux••• ••• ••• •••
Danaher Corporation••• ••• ••• •••
Foundation Medicine Inc••• ••• ••• •••
Myriad Genetics Inc••• ••• ••• •••
Roche••• ••• ••• •••
Thermo Fisher Scientific••• ••• ••• •••
QIAGEN N.V.••• ••• ••• •••

Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.

Request company profile for validation →

Report Scope & Analysis

Global Companion Diagnostic market size was USD 5.71 Billion in 2022 and it is forecasted to reach USD 14.31 Billion by 2030. Companion Diagnostic Industry's Compound Annual Growth Rate will be 13.6% from 2023 to 2030.

Introduction of Companion Diagnostic

The companion diagnostic is a medical device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. Companion diagnostics are typically highly tailored or targeted drug treatment. It helps a healthcare professional to know whether the benefits of a drug or treatment for a patient will balance any serious side effects or risks. Furthermore, companion diagnostics are used for oncology treatment and other types of companion diagnostics include mandatory complete blood count (CBC) for administration of clozapine, a drug used in the treatment of severe schizophrenia.

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Companion Diagnostic Market Analysis is witnessing significant growth in the near future.

In 2023, the Cancer segment accounted for a notable share of the Companion Diagnostic Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst at Cognitive Market Research · Cognitive Market Research
LinkedIn Profile Book Appointment

Frequently Asked Questions

Companion Diagnostic Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers Abbott Laboratories Molecular Inc, Agilent, ARUP Laboratories Inc, BioMerieux, Danaher Corporation, Foundation Medicine Inc, Myriad Genetics Inc, Roche, Thermo Fisher Scientific, QIAGEN N.V. and others are profiled in the report.
Segments include Indication, End User and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.

★ Reviews

Rate this report

Companion Diagnostic Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
License Edition

Indication Cancer, Infectious Diseases, Neurological Diseases, Others
End User Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Others
Technology Polymerase Chain Reaction, In-situ Hybridization, Immunohistochemistry, Next Generation Gene Sequencing, Others
List of Competitors Abbott Laboratories Molecular Inc, Agilent, ARUP Laboratories Inc, BioMerieux, Danaher Corporation, Foundation Medicine Inc, Myriad Genetics Inc, Roche, Thermo Fisher Scientific, QIAGEN N.V.

  • 1.1 Global Companion Diagnostic Revenue Market Size, Trend Analysis 2022 - 2034
  • 1.2 Global Companion Diagnostic Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    1.3 Global Companion Diagnostic Market Size By Regions 2022 - 2034
    • 1.3.1 Global Companion Diagnostic Revenue Market Size By Region
    • 1.3.2 Global Companion Diagnostic Volume Market Sales By Region
  • 1.4 Global Companion Diagnostic Market Size By Indication 2022 - 2034
    • 1.4.1 Cancer Market Size
    • 1.4.2 Infectious Diseases Market Size
    • 1.4.3 Neurological Diseases Market Size
    • 1.4.4 Others Market Size
  • 1.5 Global Companion Diagnostic Volume Market Sales By Indication 2022 - 2034
    • 1.5.1 Cancer Sales Volume
    • 1.5.2 Infectious Diseases Sales Volume
    • 1.5.3 Neurological Diseases Sales Volume
    • 1.5.4 Others Sales Volume
  • 1.6 Global Companion Diagnostic Market Size By End User 2022 - 2034
    • 1.6.1 Pharmaceutical & Biopharmaceutical Companies Market Size
    • 1.6.2 Reference Laboratories Market Size
    • 1.6.3 Others Market Size
  • 1.7 Global Companion Diagnostic Volume Market Sales By End User 2022 - 2034
    • 1.7.1 Pharmaceutical & Biopharmaceutical Companies Sales Volume
    • 1.7.2 Reference Laboratories Sales Volume
    • 1.7.3 Others Sales Volume
  • 1.8 Global Companion Diagnostic Market Size By Technology 2022 - 2034
    • 1.8.1 Polymerase Chain Reaction Market Size
    • 1.8.2 In-situ Hybridization Market Size
    • 1.8.3 Immunohistochemistry Market Size
    • 1.8.4 Next Generation Gene Sequencing Market Size
    • 1.8.5 Others Market Size
  • 1.9 Global Companion Diagnostic Volume Market Sales By Technology 2022 - 2034
    • 1.9.1 Polymerase Chain Reaction Sales Volume
    • 1.9.2 In-situ Hybridization Sales Volume
    • 1.9.3 Immunohistochemistry Sales Volume
    • 1.9.4 Next Generation Gene Sequencing Sales Volume
    • 1.9.5 Others Sales Volume
  • 1.10 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    1.11 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 1.11.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 1.11.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 1.11.3 Global Market Revenue Split By Indication
    • 1.11.4 Global Volume Market Split By Indication
    • 1.11.5 Global Market Revenue Split By End User
    • 1.11.6 Global Volume Market Split By End User
    • 1.11.7 Global Market Revenue Split By Technology
    • 1.11.8 Global Volume Market Split By Technology

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      1.11.9 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 2.1 North America Companion Diagnostic Market Outlook
    • 2.1.1 North America Companion Diagnostic Market Size 2022 - 2034
    • 2.1.2 North America Companion Diagnostic Volume Market Sales 2022 - 2034
    • 2.1.3 North America Companion Diagnostic Market Size By Country 2022 - 2034
    • 2.1.4 North America Companion Diagnostic Volume Market Sales By Country 2022 - 2034
    • 2.1.5 North America Companion Diagnostic Market Size by Indication 2022 - 2034
      • 2.1.5.1 North America Cancer Market Size
      • 2.1.5.2 North America Infectious Diseases Market Size
      • 2.1.5.3 North America Neurological Diseases Market Size
      • 2.1.5.4 North America Others Market Size
    • 2.1.6 North America Companion Diagnostic Volume Market Sales by Indication 2022 - 2034
      • 2.1.6.1 North America Cancer Sales Volume
      • 2.1.6.2 North America Infectious Diseases Sales Volume
      • 2.1.6.3 North America Neurological Diseases Sales Volume
      • 2.1.6.4 North America Others Sales Volume
    • 2.1.7 North America Companion Diagnostic Market Size by End User 2022 - 2034
      • 2.1.7.1 North America Pharmaceutical & Biopharmaceutical Companies Market Size
      • 2.1.7.2 North America Reference Laboratories Market Size
      • 2.1.7.3 North America Others Market Size
    • 2.1.8 North America Companion Diagnostic Volume Market Sales by End User 2022 - 2034
      • 2.1.8.1 North America Pharmaceutical & Biopharmaceutical Companies Sales Volume
      • 2.1.8.2 North America Reference Laboratories Sales Volume
      • 2.1.8.3 North America Others Sales Volume
    • 2.1.9 North America Companion Diagnostic Market Size by Technology 2022 - 2034
      • 2.1.9.1 North America Polymerase Chain Reaction Market Size
      • 2.1.9.2 North America In-situ Hybridization Market Size
      • 2.1.9.3 North America Immunohistochemistry Market Size
      • 2.1.9.4 North America Next Generation Gene Sequencing Market Size
      • 2.1.9.5 North America Others Market Size
    • 2.1.10 North America Companion Diagnostic Volume Market Sales by Technology 2022 - 2034
      • 2.1.10.1 North America Polymerase Chain Reaction Sales Volume
      • 2.1.10.2 North America In-situ Hybridization Sales Volume
      • 2.1.10.3 North America Immunohistochemistry Sales Volume
      • 2.1.10.4 North America Next Generation Gene Sequencing Sales Volume
      • 2.1.10.5 North America Others Sales Volume

  • 3.1 Europe Companion Diagnostic Market Outlook
    • 3.1.1 Europe Companion Diagnostic Market Size 2022 - 2034
    • 3.1.2 Europe Companion Diagnostic Volume Market Sales 2022 - 2034
    • 3.1.3 Europe Companion Diagnostic Market Size By Country 2022 - 2034
    • 3.1.4 Europe Companion Diagnostic Volume Market Sales By Country 2022 - 2034
    • 3.1.5 Europe Companion Diagnostic Market Size by Indication 2022 - 2034
      • 3.1.5.1 Europe Cancer Market Size
      • 3.1.5.2 Europe Infectious Diseases Market Size
      • 3.1.5.3 Europe Neurological Diseases Market Size
      • 3.1.5.4 Europe Others Market Size
    • 3.1.6 Europe Companion Diagnostic Volume Market Sales by Indication 2022 - 2034
      • 3.1.6.1 Europe Cancer Sales Volume
      • 3.1.6.2 Europe Infectious Diseases Sales Volume
      • 3.1.6.3 Europe Neurological Diseases Sales Volume
      • 3.1.6.4 Europe Others Sales Volume
    • 3.1.7 Europe Companion Diagnostic Market Size by End User 2022 - 2034
      • 3.1.7.1 Europe Pharmaceutical & Biopharmaceutical Companies Market Size
      • 3.1.7.2 Europe Reference Laboratories Market Size
      • 3.1.7.3 Europe Others Market Size
    • 3.1.8 Europe Companion Diagnostic Volume Market Sales by End User 2022 - 2034
      • 3.1.8.1 Europe Pharmaceutical & Biopharmaceutical Companies Sales Volume
      • 3.1.8.2 Europe Reference Laboratories Sales Volume
      • 3.1.8.3 Europe Others Sales Volume
    • 3.1.9 Europe Companion Diagnostic Market Size by Technology 2022 - 2034
      • 3.1.9.1 Europe Polymerase Chain Reaction Market Size
      • 3.1.9.2 Europe In-situ Hybridization Market Size
      • 3.1.9.3 Europe Immunohistochemistry Market Size
      • 3.1.9.4 Europe Next Generation Gene Sequencing Market Size
      • 3.1.9.5 Europe Others Market Size
    • 3.1.10 Europe Companion Diagnostic Volume Market Sales by Technology 2022 - 2034
      • 3.1.10.1 Europe Polymerase Chain Reaction Sales Volume
      • 3.1.10.2 Europe In-situ Hybridization Sales Volume
      • 3.1.10.3 Europe Immunohistochemistry Sales Volume
      • 3.1.10.4 Europe Next Generation Gene Sequencing Sales Volume
      • 3.1.10.5 Europe Others Sales Volume

  • 4.1 Asia Pacific Companion Diagnostic Market Outlook
    • 4.1.1 Asia Pacific Companion Diagnostic Market Size 2022 - 2034
    • 4.1.2 Asia Pacific Companion Diagnostic Volume Market Sales 2022 - 2034
    • 4.1.3 Asia Pacific Companion Diagnostic Market Size By Country 2022 - 2034
    • 4.1.4 Asia Pacific Companion Diagnostic Volume Market Sales By Country 2022 - 2034
    • 4.1.5 Asia Pacific Companion Diagnostic Market Size by Indication 2022 - 2034
      • 4.1.5.1 Asia Pacific Cancer Market Size
      • 4.1.5.2 Asia Pacific Infectious Diseases Market Size
      • 4.1.5.3 Asia Pacific Neurological Diseases Market Size
      • 4.1.5.4 Asia Pacific Others Market Size
    • 4.1.6 Asia Pacific Companion Diagnostic Volume Market Sales by Indication 2022 - 2034
      • 4.1.6.1 Asia Pacific Cancer Sales Volume
      • 4.1.6.2 Asia Pacific Infectious Diseases Sales Volume
      • 4.1.6.3 Asia Pacific Neurological Diseases Sales Volume
      • 4.1.6.4 Asia Pacific Others Sales Volume
    • 4.1.7 Asia Pacific Companion Diagnostic Market Size by End User 2022 - 2034
      • 4.1.7.1 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market Size
      • 4.1.7.2 Asia Pacific Reference Laboratories Market Size
      • 4.1.7.3 Asia Pacific Others Market Size
    • 4.1.8 Asia Pacific Companion Diagnostic Volume Market Sales by End User 2022 - 2034
      • 4.1.8.1 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Sales Volume
      • 4.1.8.2 Asia Pacific Reference Laboratories Sales Volume
      • 4.1.8.3 Asia Pacific Others Sales Volume
    • 4.1.9 Asia Pacific Companion Diagnostic Market Size by Technology 2022 - 2034
      • 4.1.9.1 Asia Pacific Polymerase Chain Reaction Market Size
      • 4.1.9.2 Asia Pacific In-situ Hybridization Market Size
      • 4.1.9.3 Asia Pacific Immunohistochemistry Market Size
      • 4.1.9.4 Asia Pacific Next Generation Gene Sequencing Market Size
      • 4.1.9.5 Asia Pacific Others Market Size
    • 4.1.10 Asia Pacific Companion Diagnostic Volume Market Sales by Technology 2022 - 2034
      • 4.1.10.1 Asia Pacific Polymerase Chain Reaction Sales Volume
      • 4.1.10.2 Asia Pacific In-situ Hybridization Sales Volume
      • 4.1.10.3 Asia Pacific Immunohistochemistry Sales Volume
      • 4.1.10.4 Asia Pacific Next Generation Gene Sequencing Sales Volume
      • 4.1.10.5 Asia Pacific Others Sales Volume

  • 5.1 South America Companion Diagnostic Market Outlook
    • 5.1.1 South America Companion Diagnostic Market Size 2022 - 2034
    • 5.1.2 South America Companion Diagnostic Volume Market Sales 2022 - 2034
    • 5.1.3 South America Companion Diagnostic Market Size By Country 2022 - 2034
    • 5.1.4 South America Companion Diagnostic Volume Market Sales By Country 2022 - 2034
    • 5.1.5 South America Companion Diagnostic Market Size by Indication 2022 - 2034
      • 5.1.5.1 South America Cancer Market Size
      • 5.1.5.2 South America Infectious Diseases Market Size
      • 5.1.5.3 South America Neurological Diseases Market Size
      • 5.1.5.4 South America Others Market Size
    • 5.1.6 South America Companion Diagnostic Volume Market Sales by Indication 2022 - 2034
      • 5.1.6.1 South America Cancer Sales Volume
      • 5.1.6.2 South America Infectious Diseases Sales Volume
      • 5.1.6.3 South America Neurological Diseases Sales Volume
      • 5.1.6.4 South America Others Sales Volume
    • 5.1.7 South America Companion Diagnostic Market Size by End User 2022 - 2034
      • 5.1.7.1 South America Pharmaceutical & Biopharmaceutical Companies Market Size
      • 5.1.7.2 South America Reference Laboratories Market Size
      • 5.1.7.3 South America Others Market Size
    • 5.1.8 South America Companion Diagnostic Volume Market Sales by End User 2022 - 2034
      • 5.1.8.1 South America Pharmaceutical & Biopharmaceutical Companies Sales Volume
      • 5.1.8.2 South America Reference Laboratories Sales Volume
      • 5.1.8.3 South America Others Sales Volume
    • 5.1.9 South America Companion Diagnostic Market Size by Technology 2022 - 2034
      • 5.1.9.1 South America Polymerase Chain Reaction Market Size
      • 5.1.9.2 South America In-situ Hybridization Market Size
      • 5.1.9.3 South America Immunohistochemistry Market Size
      • 5.1.9.4 South America Next Generation Gene Sequencing Market Size
      • 5.1.9.5 South America Others Market Size
    • 5.1.10 South America Companion Diagnostic Volume Market Sales by Technology 2022 - 2034
      • 5.1.10.1 South America Polymerase Chain Reaction Sales Volume
      • 5.1.10.2 South America In-situ Hybridization Sales Volume
      • 5.1.10.3 South America Immunohistochemistry Sales Volume
      • 5.1.10.4 South America Next Generation Gene Sequencing Sales Volume
      • 5.1.10.5 South America Others Sales Volume

  • 6.1 Middle East Companion Diagnostic Market Outlook
    • 6.1.1 Middle East Companion Diagnostic Market Size 2022 - 2034
    • 6.1.2 Middle East Companion Diagnostic Volume Market Sales 2022 - 2034
    • 6.1.3 Middle East Companion Diagnostic Market Size By Country 2022 - 2034
    • 6.1.4 Middle East Companion Diagnostic Volume Market Sales By Country 2022 - 2034
    • 6.1.5 Middle East Companion Diagnostic Market Size by Indication 2022 - 2034
      • 6.1.5.1 Middle East Cancer Market Size
      • 6.1.5.2 Middle East Infectious Diseases Market Size
      • 6.1.5.3 Middle East Neurological Diseases Market Size
      • 6.1.5.4 Middle East Others Market Size
    • 6.1.6 Middle East Companion Diagnostic Volume Market Sales by Indication 2022 - 2034
      • 6.1.6.1 Middle East Cancer Sales Volume
      • 6.1.6.2 Middle East Infectious Diseases Sales Volume
      • 6.1.6.3 Middle East Neurological Diseases Sales Volume
      • 6.1.6.4 Middle East Others Sales Volume
    • 6.1.7 Middle East Companion Diagnostic Market Size by End User 2022 - 2034
      • 6.1.7.1 Middle East Pharmaceutical & Biopharmaceutical Companies Market Size
      • 6.1.7.2 Middle East Reference Laboratories Market Size
      • 6.1.7.3 Middle East Others Market Size
    • 6.1.8 Middle East Companion Diagnostic Volume Market Sales by End User 2022 - 2034
      • 6.1.8.1 Middle East Pharmaceutical & Biopharmaceutical Companies Sales Volume
      • 6.1.8.2 Middle East Reference Laboratories Sales Volume
      • 6.1.8.3 Middle East Others Sales Volume
    • 6.1.9 Middle East Companion Diagnostic Market Size by Technology 2022 - 2034
      • 6.1.9.1 Middle East Polymerase Chain Reaction Market Size
      • 6.1.9.2 Middle East In-situ Hybridization Market Size
      • 6.1.9.3 Middle East Immunohistochemistry Market Size
      • 6.1.9.4 Middle East Next Generation Gene Sequencing Market Size
      • 6.1.9.5 Middle East Others Market Size
    • 6.1.10 Middle East Companion Diagnostic Volume Market Sales by Technology 2022 - 2034
      • 6.1.10.1 Middle East Polymerase Chain Reaction Sales Volume
      • 6.1.10.2 Middle East In-situ Hybridization Sales Volume
      • 6.1.10.3 Middle East Immunohistochemistry Sales Volume
      • 6.1.10.4 Middle East Next Generation Gene Sequencing Sales Volume
      • 6.1.10.5 Middle East Others Sales Volume

  • 7.1 Africa Companion Diagnostic Market Outlook
    • 7.1.1 Africa Companion Diagnostic Market Size 2022 - 2034
    • 7.1.2 Africa Companion Diagnostic Volume Market Sales 2022 - 2034
    • 7.1.3 Africa Companion Diagnostic Market Size By Country 2022 - 2034
    • 7.1.4 Africa Companion Diagnostic Volume Market Sales By Country 2022 - 2034
    • 7.1.5 Africa Companion Diagnostic Market Size by Indication 2022 - 2034
      • 7.1.5.1 Africa Cancer Market Size
      • 7.1.5.2 Africa Infectious Diseases Market Size
      • 7.1.5.3 Africa Neurological Diseases Market Size
      • 7.1.5.4 Africa Others Market Size
    • 7.1.6 Africa Companion Diagnostic Volume Market Sales by Indication 2022 - 2034
      • 7.1.6.1 Africa Cancer Sales Volume
      • 7.1.6.2 Africa Infectious Diseases Sales Volume
      • 7.1.6.3 Africa Neurological Diseases Sales Volume
      • 7.1.6.4 Africa Others Sales Volume
    • 7.1.7 Africa Companion Diagnostic Market Size by End User 2022 - 2034
      • 7.1.7.1 Africa Pharmaceutical & Biopharmaceutical Companies Market Size
      • 7.1.7.2 Africa Reference Laboratories Market Size
      • 7.1.7.3 Africa Others Market Size
    • 7.1.8 Africa Companion Diagnostic Volume Market Sales by End User 2022 - 2034
      • 7.1.8.1 Africa Pharmaceutical & Biopharmaceutical Companies Sales Volume
      • 7.1.8.2 Africa Reference Laboratories Sales Volume
      • 7.1.8.3 Africa Others Sales Volume
    • 7.1.9 Africa Companion Diagnostic Market Size by Technology 2022 - 2034
      • 7.1.9.1 Africa Polymerase Chain Reaction Market Size
      • 7.1.9.2 Africa In-situ Hybridization Market Size
      • 7.1.9.3 Africa Immunohistochemistry Market Size
      • 7.1.9.4 Africa Next Generation Gene Sequencing Market Size
      • 7.1.9.5 Africa Others Market Size
    • 7.1.10 Africa Companion Diagnostic Volume Market Sales by Technology 2022 - 2034
      • 7.1.10.1 Africa Polymerase Chain Reaction Sales Volume
      • 7.1.10.2 Africa In-situ Hybridization Sales Volume
      • 7.1.10.3 Africa Immunohistochemistry Sales Volume
      • 7.1.10.4 Africa Next Generation Gene Sequencing Sales Volume
      • 7.1.10.5 Africa Others Sales Volume

  • 8.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      8.1.1 Global Companion Diagnostic Market Analysis by Key Players
    • 8.1.2 Global Companion Diagnostic Market Volume and Share by Key Players
    • 8.1.3 Top Players Ranking 2024
    • 8.1.4 New Product Launch Analysis
    • 8.1.5 Industry Mergers and Acquisition Analysis
  • 8.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.1 Abbott Laboratories Molecular Inc
      • 8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.1.2 Business Overview
      • 8.2.1.3 Financials (Subject to data availability)
      • 8.2.1.4 R&D Investment (Subject to data availability)
      • 8.2.1.5 Product Types Specification
      • 8.2.1.6 Business Strategy
      • 8.2.1.7 Recent Developments
      • 8.2.1.8 Management Change
      • 8.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.2 Agilent
      • 8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.2.2 Business Overview
      • 8.2.2.3 Financials (Subject to data availability)
      • 8.2.2.4 R&D Investment (Subject to data availability)
      • 8.2.2.5 Product Types Specification
      • 8.2.2.6 Business Strategy
      • 8.2.2.7 Recent Developments
      • 8.2.2.8 Management Change
      • 8.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.3 ARUP Laboratories Inc
      • 8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.3.2 Business Overview
      • 8.2.3.3 Financials (Subject to data availability)
      • 8.2.3.4 R&D Investment (Subject to data availability)
      • 8.2.3.5 Product Types Specification
      • 8.2.3.6 Business Strategy
      • 8.2.3.7 Recent Developments
      • 8.2.3.8 Management Change
      • 8.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.4 BioMerieux
      • 8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.4.2 Business Overview
      • 8.2.4.3 Financials (Subject to data availability)
      • 8.2.4.4 R&D Investment (Subject to data availability)
      • 8.2.4.5 Product Types Specification
      • 8.2.4.6 Business Strategy
      • 8.2.4.7 Recent Developments
      • 8.2.4.8 Management Change
      • 8.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.5 Danaher Corporation
      • 8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.5.2 Business Overview
      • 8.2.5.3 Financials (Subject to data availability)
      • 8.2.5.4 R&D Investment (Subject to data availability)
      • 8.2.5.5 Product Types Specification
      • 8.2.5.6 Business Strategy
      • 8.2.5.7 Recent Developments
      • 8.2.5.8 Management Change
      • 8.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.6 Foundation Medicine Inc
      • 8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.6.2 Business Overview
      • 8.2.6.3 Financials (Subject to data availability)
      • 8.2.6.4 R&D Investment (Subject to data availability)
      • 8.2.6.5 Product Types Specification
      • 8.2.6.6 Business Strategy
      • 8.2.6.7 Recent Developments
      • 8.2.6.8 Management Change
      • 8.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.7 Myriad Genetics Inc
      • 8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.7.2 Business Overview
      • 8.2.7.3 Financials (Subject to data availability)
      • 8.2.7.4 R&D Investment (Subject to data availability)
      • 8.2.7.5 Product Types Specification
      • 8.2.7.6 Business Strategy
      • 8.2.7.7 Recent Developments
      • 8.2.7.8 Management Change
      • 8.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.8 Roche
      • 8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.8.2 Business Overview
      • 8.2.8.3 Financials (Subject to data availability)
      • 8.2.8.4 R&D Investment (Subject to data availability)
      • 8.2.8.5 Product Types Specification
      • 8.2.8.6 Business Strategy
      • 8.2.8.7 Recent Developments
      • 8.2.8.8 Management Change
      • 8.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.9 Thermo Fisher Scientific
      • 8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.9.2 Business Overview
      • 8.2.9.3 Financials (Subject to data availability)
      • 8.2.9.4 R&D Investment (Subject to data availability)
      • 8.2.9.5 Product Types Specification
      • 8.2.9.6 Business Strategy
      • 8.2.9.7 Recent Developments
      • 8.2.9.8 Management Change
      • 8.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      8.2.10 QIAGEN N.V.
      • 8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 8.2.10.2 Business Overview
      • 8.2.10.3 Financials (Subject to data availability)
      • 8.2.10.4 R&D Investment (Subject to data availability)
      • 8.2.10.5 Product Types Specification
      • 8.2.10.6 Business Strategy
      • 8.2.10.7 Recent Developments
      • 8.2.10.8 Management Change
      • 8.2.10.9 S.W.O.T Analysis

  • 9.1 Market Drivers
  • 9.2 Market Restraints
  • 9.3 Market Trends
  • 9.4 Market Opportunity
  • 9.5 Technological Road Map (Subject to Data Availability)
  • 9.6 Product Life Cycle (Subject to Data Availability)
  • 9.7 Customer and Buyer Behavior Analysis
    • 9.7.1 Consumer Demographics and Target Audience Assessment
    • 9.7.2 Consumer Purchase Behavior and Demand Assessment
    • 9.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 9.7.4 Digital Consumer Engagement and Online Adoption Analysis
    • 9.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 9.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 9.7.7 Buyer Decision-Making & Purchase Influence Assessment
    • 9.7.8 Customer Expectations & Service Experience Evaluation
    • 9.7.9 Vendor Selection & Supplier Preference Analysis
    • 9.7.10 Customer Retention & Loyalty Strategy Assessment
    • 9.7.11 Pricing Sensitivity & Value Perception Analysis
    • 9.7.12 Customer Segmentation & Demand Pattern Analysis
    • 9.7.13 Relationship Management & Strategic Partnership Trends
  • 9.8 Market Attractiveness Analysis
  • 9.9 PESTEL Analysis
    • 9.9.1 Political Factors
    • 9.9.2 Economic Factors
    • 9.9.3 Social Factors
    • 9.9.4 Technological Factors
    • 9.9.5 Legal Factors
    • 9.9.6 Environmental Factors
  • 9.10 Industrial Chain Analysis (Subject to Data Availability)
    • 9.10.1 Industry Chain Analysis
    • 9.10.2 Manufacturing Cost Analysis
    • 9.10.3 Supply Side Analysis
      • 9.10.3.1 Raw Material Analysis
      • 9.10.3.2 Raw Material Procurement Analysis
      • 9.10.3.3 Raw Material Price Trend Analysis
  • 9.11 Porter’s Five Forces Analysis
    • 9.11.1 Bargaining Power of Suppliers
    • 9.11.2 Bargaining Power of Buyers
    • 9.11.3 Threat of New Entrants
    • 9.11.4 Threat of Substitutes
    • 9.11.5 Degree of Competition
  • 9.12 Patent Analysis (Subject to Data Availability)
  • 9.13 ESG Analysis
  • 9.14 Geopolitical Outlook
    • 9.14.1 Global Power Realignment & Strategic Alliances
    • 9.14.2 Geopolitical Risk Landscape & Conflict Hotspots
    • 9.14.3 International Trade Relations & Market Access Environment
    • 9.14.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
    • 9.14.5 Supply Chain Resilience, Localization & Resource Nationalism
    • 9.14.6 Technology Sovereignty & Digital Geopolitics
    • 9.14.7 Strategic Implications for Investment, Growth & Market Entry

  • This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy

    9.15 AI & Market Transformation
    • 9.15.1 Competitive Landscape Disruption & Strategic Shifts
    • 9.15.2 AI-Driven Transformation of Industry Value Chain
    • 9.15.3 Evolution of Business Models & Revenue Streams
    • 9.15.4 Operational Efficiency & Cost Structure Transformation
    • 9.15.5 Product, Service & Innovation Acceleration
    • 9.15.6 Customer Behavior & Demand Evolution
    • 9.15.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

  • 10.1 Cancer
    • 10.1.1 Global Companion Diagnostic Revenue Market Size and Share by Cancer 2022 - 2034
    • 10.1.2 Global Companion Diagnostic Volume Market Sales by Cancer 2022 - 2034
  • 10.2 Infectious Diseases
    • 10.2.1 Global Companion Diagnostic Revenue Market Size and Share by Infectious Diseases 2022 - 2034
    • 10.2.2 Global Companion Diagnostic Volume Market Sales by Infectious Diseases 2022 - 2034
  • 10.3 Neurological Diseases
    • 10.3.1 Global Companion Diagnostic Revenue Market Size and Share by Neurological Diseases 2022 - 2034
    • 10.3.2 Global Companion Diagnostic Volume Market Sales by Neurological Diseases 2022 - 2034
  • 10.4 Others
    • 10.4.1 Global Companion Diagnostic Revenue Market Size and Share by Others 2022 - 2034
    • 10.4.2 Global Companion Diagnostic Volume Market Sales by Others 2022 - 2034

  • 11.1 Pharmaceutical & Biopharmaceutical Companies
    • 11.1.1 Global Companion Diagnostic Revenue Market Size and Share by Pharmaceutical & Biopharmaceutical Companies 2022 - 2034
    • 11.1.2 Global Companion Diagnostic Volume Market Sales by Pharmaceutical & Biopharmaceutical Companies 2022 - 2034
  • 11.2 Reference Laboratories
    • 11.2.1 Global Companion Diagnostic Revenue Market Size and Share by Reference Laboratories 2022 - 2034
    • 11.2.2 Global Companion Diagnostic Volume Market Sales by Reference Laboratories 2022 - 2034
  • 11.3 Others
    • 11.3.1 Global Companion Diagnostic Revenue Market Size and Share by Others 2022 - 2034
    • 11.3.2 Global Companion Diagnostic Volume Market Sales by Others 2022 - 2034

  • 12.1 Polymerase Chain Reaction
    • 12.1.1 Global Companion Diagnostic Revenue Market Size and Share by Polymerase Chain Reaction 2022 - 2034
    • 12.1.2 Global Companion Diagnostic Volume Market Sales by Polymerase Chain Reaction 2022 - 2034
  • 12.2 In-situ Hybridization
    • 12.2.1 Global Companion Diagnostic Revenue Market Size and Share by In-situ Hybridization 2022 - 2034
    • 12.2.2 Global Companion Diagnostic Volume Market Sales by In-situ Hybridization 2022 - 2034
  • 12.3 Immunohistochemistry
    • 12.3.1 Global Companion Diagnostic Revenue Market Size and Share by Immunohistochemistry 2022 - 2034
    • 12.3.2 Global Companion Diagnostic Volume Market Sales by Immunohistochemistry 2022 - 2034
  • 12.4 Next Generation Gene Sequencing
    • 12.4.1 Global Companion Diagnostic Revenue Market Size and Share by Next Generation Gene Sequencing 2022 - 2034
    • 12.4.2 Global Companion Diagnostic Volume Market Sales by Next Generation Gene Sequencing 2022 - 2034
  • 12.5 Others
    • 12.5.1 Global Companion Diagnostic Revenue Market Size and Share by Others 2022 - 2034
    • 12.5.2 Global Companion Diagnostic Volume Market Sales by Others 2022 - 2034

  • 13.1 Company Gap Assessment Analysis
  • 13.2 Product & Service Portfolio Gap Analysis
  • 13.3 Demand-Supply Imbalance Analysis
  • 13.4 Market Opportunity & Unmet Needs Analysis
  • 13.5 Technology Adoption & Digital Transformation Gap Analysis
  • 13.6 Operational Efficiency & Process Gap Analysis
  • 13.7 Infrastructure & Capacity Gap Analysis
  • 13.8 Geographic Coverage & Distribution Gap Analysis
  • 13.9 Investment Opportunity & Funding Gap Analysis
  • 13.10 Pricing Structure & Margin Gap Analysis
  • 13.11 Innovation & R&D Capability Gap Analysis
  • 13.12 Policy, Compliance & Regulatory Gap Analysis
  • 13.13 Customer Experience & Expectation Gap Analysis
  • 13.14 Future Growth Opportunity Gap Analysis
  • 13.15 Market Accessibility & Penetration Gap Analysis

  • 14.1 Gross Margin Overview and Industry Profitability Trends
  • 14.2 Regional Gross Margin Performance Analysis
  • 14.3 Supply Chain and Distribution Impact on Gross Margins
  • 14.4 Pricing Strategy and Value-Added Margin Assessment
  • 14.5 Key Factors Influencing Gross Margin Variability
  • 14.6 Future Gross Margin Outlook and Profitability Trends

  • 15.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    15.2 Analyst Point of View
  • 15.3 Assumptions and Acronyms

  • 16.1 Primary Data Collection
    • 16.1.1 Steps for Primary Data Collection
      • 16.1.1.1 Identification of KOL
    • 16.1.2 Backward Integration
    • 16.1.3 Forward Integration
    • 16.1.4 How Primary Research Help Us
    • 16.1.5 Modes of Primary Research
  • 16.2 Secondary Research
    • 16.2.1 How Secondary Research Help Us
    • 16.2.2 Sources of Secondary Research
  • 16.3 Data Validation
    • 16.3.1 Data Triangulation
    • 16.3.2 Top Down & Bottom Up Approach
    • 16.3.3 Cross check KOL Responses with Secondary Data
  • 16.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Companion Diagnostic Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 10+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Companion Diagnostic Market

Sources from Medical Devices & Consumables Industry

How We Serve You

The Three Pillars of End-to-End Market Research Services

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Companion Diagnostic Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the companion diagnostic market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.